Intracranial hemorrhage in patients treated with bevacizumab and low-molecular weight heparin.
Nguyen
Teri D
TD
Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Abrey
Lauren E
LE
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants / Q000627:therapeutic use; D000068258:Bevacizumab; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D020300:Intracranial Hemorrhages / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011859:Radiography
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D000068258:Bevacizumab